Alberto Gimona

3.2k total citations · 1 hit paper
23 papers, 2.3k citations indexed

About

Alberto Gimona is a scholar working on Surgery, Rheumatology and Pharmacology. According to data from OpenAlex, Alberto Gimona has authored 23 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Rheumatology and 6 papers in Pharmacology. Recurrent topics in Alberto Gimona's work include Osteoarthritis Treatment and Mechanisms (9 papers), Inflammatory mediators and NSAID effects (6 papers) and Lower Extremity Biomechanics and Pathologies (5 papers). Alberto Gimona is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (9 papers), Inflammatory mediators and NSAID effects (6 papers) and Lower Extremity Biomechanics and Pathologies (5 papers). Alberto Gimona collaborates with scholars based in United States, Switzerland and Germany. Alberto Gimona's co-authors include Gerhard Krammer, Christopher J. Hawkey, Xavier Gitton, Eduardo Mysler, Patrice Matchaba, Gerd R Burmester, Michael Doherty, Marc C. Hochberg, Thomas J. Schnitzer and B. Mellein and has published in prestigious journals such as The Lancet, Gastroenterology and The American Journal of Medicine.

In The Last Decade

Alberto Gimona

23 papers receiving 2.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study

2000 785 citations Charles H. Chesnut, Stuart L. Silverman et al. The American Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alberto Gimona United States	12	858	705	694	558	506	23	2.3k
Sybille Franke Germany	27	132 0.2×	167 0.2×	326 0.5×	274 0.5×	731 1.4×	63	2.5k
Piotr Głuszko Poland	18	148 0.2×	452 0.6×	105 0.2×	224 0.4×	167 0.3×	76	1.3k
Barbara G. Kravitz United States	15	288 0.3×	906 1.3×	361 0.5×	49 0.1×	1.9k 3.8×	23	3.6k
Mogher Khamaisi Israel	22	49 0.1×	204 0.3×	213 0.3×	115 0.2×	372 0.7×	52	2.0k
David Hürlimann Switzerland	22	304 0.4×	583 0.8×	24 0.0×	320 0.6×	486 1.0×	45	2.9k
Kaisa Mäki-Petäjä United Kingdom	26	70 0.1×	390 0.6×	37 0.1×	426 0.8×	354 0.7×	52	2.9k
Richard E. Gilbert Australia	24	180 0.2×	289 0.4×	42 0.1×	89 0.2×	579 1.1×	44	2.2k
Yong‐Ki Min South Korea	25	56 0.1×	677 1.0×	235 0.3×	46 0.1×	449 0.9×	101	2.0k
Li Qin China	25	55 0.1×	199 0.3×	71 0.1×	80 0.1×	509 1.0×	88	1.9k

Countries citing papers authored by Alberto Gimona

Since Specialization

Citations

This map shows the geographic impact of Alberto Gimona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Gimona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Gimona more than expected).

Fields of papers citing papers by Alberto Gimona

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Gimona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Gimona. The network helps show where Alberto Gimona may publish in the future.

Co-authorship network of co-authors of Alberto Gimona

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Gimona. A scholar is included among the top collaborators of Alberto Gimona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Gimona. Alberto Gimona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fietze, Ingo, Claudio L. Bassetti, David Mayleben, et al.. (2022). Effects of daridorexant on sleep and daytime functioning in older adults with insomnia. American Journal of Geriatric Psychiatry. 30(4). S69–S70. 3 indexed citations

Zammit, Gary, David Mayleben, Ingo Fietze, et al.. (2021). 344 Daridorexant Improves Total Sleep Time (TST) in Insomnia Patients Without Altering the Proportion of Sleep Stages. SLEEP. 44(Supplement_2). A137–A138. 1 indexed citations

Frey, Aline, et al.. (2021). Measures to mitigate disruption due to the COVID-19 pandemic of the MODIFY phase 3 pivotal trial in patients with Fabry disease. Molecular Genetics and Metabolism. 132(2). S39–S40. 1 indexed citations

Schlesinger, Naomi, Rieke Alten, Thomas Bardin, et al.. (2012). Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions. Annals of the Rheumatic Diseases. 71(11). 1839–1848. 250 indexed citations

Wirth, W., R. Buck, Michael C. Nevitt, et al.. (2011). MRI-based extended ordered values more efficiently differentiate cartilage loss in knees with and without joint space narrowing than region-specific approaches using MRI or radiography – data from the OA initiative. Osteoarthritis and Cartilage. 19(6). 689–699. 58 indexed citations

Frobell, R., W. Wirth, Michael C. Nevitt, et al.. (2010). Presence, location, type and size of denuded areas of subchondral bone in the knee as a function of radiographic stage of OA – data from the OA initiative. Osteoarthritis and Cartilage. 18(5). 668–676. 21 indexed citations

Eckstein, F., Michael C. Nevitt, Alberto Gimona, et al.. (2010). Rates of change and sensitivity to change in cartilage morphology in healthy knees and in knees with mild, moderate, and end‐stage radiographic osteoarthritis: Results from 831 participants from the osteoarthritis initiative. Arthritis Care & Research. 63(3). 311–319. 60 indexed citations

Frobell, R., Michael C. Nevitt, M. Hudelmaier, et al.. (2010). Femorotibial subchondral bone area and regional cartilage thickness: A cross‐sectional description in healthy reference cases and various radiographic stages of osteoarthritis in 1,003 knees from the Osteoarthritis Initiative. Arthritis Care & Research. 62(11). 1612–1623. 62 indexed citations

Wirth, W., Sylvain Larroque, Richard Y. Davies, et al.. (2010). Comparison of 1-year vs 2-year change in regional cartilage thickness in osteoarthritis results from 346 participants from the Osteoarthritis Initiative. Osteoarthritis and Cartilage. 19(1). 74–83. 41 indexed citations

10.

Wirth, W., Michael C. Nevitt, M.-P. Hellio Le Graverand, et al.. (2009). Sensitivity to change of cartilage morphometry using coronal FLASH, sagittal DESS, and coronal MPR DESS protocols – comparative data from the osteoarthritis initiative (OAI). Osteoarthritis and Cartilage. 18(4). 547–554. 65 indexed citations

11.

Ladel, C., et al.. (2008). 73 RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR 18 AS THERAPY FOR OSTEOARTHRITIS: A DOG MENISCECTOMY MODEL STUDY. Osteoarthritis and Cartilage. 16. S46–S46. 1 indexed citations

12.

Schnitzer, Thomas J., Gerd R Burmester, Eduardo Mysler, et al.. (2004). Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial. The Lancet. 364(9435). 665–674. 493 indexed citations

13.

Kivitz, Alan, et al.. (2004). Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis. Alimentary Pharmacology & Therapeutics. 19(11). 1189–1198. 52 indexed citations

14.

Farkouh, Michael E., Howard S. Kirshner, Robert A. Harrington, et al.. (2004). Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial. The Lancet. 364(9435). 675–684. 364 indexed citations

15.

Grifka, Joachim, J. Zacher, Jacques P. Brown, et al.. (2004). Efficacy and tolerability of lumiracoxib versus placebo in patients with osteoarthritis of the hand.. PubMed. 22(5). 589–96. 46 indexed citations

16.

Hawkey, Christopher J., et al.. (2003). The gastrointestinal tolerability of a novel COX-2 selective inhibitor, lumiracoxb, in osteoarthritis patients: Pooled analysis. Gastroenterology. 124(4). A512–A512. 2 indexed citations

17.

Tannenbaum, H, Francis Bérenbaum, Jean‐Yves Reginster, et al.. (2002). Lumiracoxib (Prexige) is effective in the treatment of osteoarthritis of the knee: a 13-week, placebo-controlled, active-comparator, double-blind study. Open Repository and Bibliography (University of Liège). 7 indexed citations

18.

Chesnut, Charles H., Stuart L. Silverman, Kim Andriano, et al.. (2000). A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. The American Journal of Medicine. 109(4). 267–276. 785 indexed citations breakdown →

19.

Delmas, Pierre & Alberto Gimona. (1996). Osteoporosis prevention clinical study program. European Journal of Obstetrics & Gynecology and Reproductive Biology. 64. S39–S45. 1 indexed citations

20.

Gimona, Alberto, et al.. (1995). Pharmacokinetics of Estradiol and Estrone following Repeated Administration of Menorest??, a New Estrogen Transdermal Delivery System, in Menopausal Women. Clinical Drug Investigation. 10(2). 96–103. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact